Kiyoshi Fukuhara Selected Research

Oxidized LDL Receptors

11/2017

Enhanced radical scavenging activity of a procyanidin B3 analogue comprised of a dimer of planar catechin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Fukuhara Research Topics

Disease

7	Neoplasms (Cancer) 02/2024 - 09/2005
5	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 03/2013
4	Carcinogenesis 05/2012 - 12/2004
3	Colonic Neoplasms (Colon Cancer) 01/2023 - 04/2011
2	Obesity 02/2019 - 01/2013
2	Arteriosclerosis 11/2017 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2008 - 11/2002
1	Osteoporosis 01/2024
1	Atherosclerotic Plaque (Atheroma) 10/2020
1	Contact Dermatitis (Eczema, Contact) 02/2019
1	Allergic Contact Dermatitis 02/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Stroke (Strokes) 01/2015
1	Dementia (Dementias) 03/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013
1	Insulin Resistance 01/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Necrosis 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2009
1	Neuroblastoma 01/2009

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 02/2024 - 03/2006
5	Catechin (Z 7300)IBA 02/2024 - 01/2017
5	ResveratrolIBA 01/2015 - 11/2002
3	Peptides (Polypeptides)IBA 01/2023 - 01/2016
3	oxidized low density lipoproteinIBA 10/2020 - 01/2017
2	CateninsIBA 01/2023 - 11/2022
2	LectinsIBA 11/2017 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 11/2016 - 01/2016
2	rubiadinIBA 05/2012 - 01/2010
2	lucidinIBA 05/2012 - 01/2010
2	Coloring Agents (Dyes)IBA 04/2011 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 04/2011 - 01/2010
2	AnthraquinonesIBA 01/2010 - 06/2007
1	EnzymesIBA 02/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	Cell-Penetrating PeptidesIBA 01/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	HDL LipoproteinsIBA 10/2020
1	Silybin (Lagosa)IBA 09/2020
1	milk-thistle extractIBA 09/2020
1	DinitrofluorobenzeneIBA 02/2019
1	HaptensIBA 02/2019
1	Proanthocyanidins (Procyanidins)IBA 11/2017
1	Oxidized LDL ReceptorsIBA 11/2017
1	proanthocyanidinIBA 01/2017
1	Protein AggregatesIBA 01/2016
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	AllantoinIBA 03/2013
1	3-hydroxykynurenineIBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	StilbenesIBA 01/2013
1	hydroxide ionIBA 01/2013
1	SulfotransferasesIBA 04/2011
1	mitotracker green FMIBA 04/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2011
1	Analgesics (Analgesic Drugs)IBA 01/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2011
1	AntipyreticsIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2009
1	norsalsolinolIBA 01/2009
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2009
1	NeurotoxinsIBA 01/2009
1	Cytochromes c (Cytochrome c)IBA 01/2009
1	9-nitroanthraceneIBA 06/2007
1	PolyphenolsIBA 03/2006
1	1-benzyl-1,4-dihydronicotinamideIBA 09/2005
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2005
1	pyridine N-oxideIBA 09/2005
1	catechol (pyrocatechol)IBA 09/2005
1	GentisatesIBA 09/2005
1	Antineoplastic Agents (Antineoplastics)IBA 09/2005
1	Hydroxyl RadicalIBA 09/2005
1	DNA AdductsIBA 12/2004

Therapy/Procedure

2	Therapeutics 11/2022 - 06/2007